[ Main Page | Editorial Board | About | Instructions ]
[ Table of Contents | Archive | Archive Search | Online Submission | Sponsor | E-mail ]

Turkish Journal of Cancer
2007, Volume 37, Number 2
31 article(s) found.
  • The prognostic predictors for disease free survival and overall survival in stage I-III breast cancer patients treated with adjuvant cyclophosphamide-adriamycin-5-fluorouracil (CAF) chemotherapy
         BAŞAK OYAN1, NİLÜFER GÜLER1, AYŞE KARS1, ALEV TÜRKER1, KADRİ ALTUNDAĞ1, YAVUZ ÖZIŞIK1, EŞMEN BALTALI1, İSMAİL ÇELİK1, İBRAHİM BARIŞTA1, İBRAHİM GÜLLÜ1, ŞUAYİB YALÇIN1, ERHAN HAMALOĞLU2, ZAFER ÖNER2, GÜLTEN TEKUZMAN1
  • Treatment delay in breast cancer; does it really have an impact on prognosis?
         MUSTAFA SAMUR1, HAKAN S. BOZCUK1, GAMZE DALMAZ2, ŞEYDA KARAVELİ3, FUNDA GÜL KÖSEOĞLU2, TANER ÇOLAK4, ELİF PESTERELİ3
  • Stereologic estimation of mean nuclear volume in invasive ductal carcinoma of the breast: It’s impact on prognosis
         GÜLSÜM ÖZLEM ELPEK1, ŞEYDA KARAVELİ1, MEHMET ALİ ÖZGÜR1, OSMAN SAKA2
  • Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment?
         MUSTAFA SAMUR1, MELAHAT GARİPAĞAOĞLU2, HAKAN AKBULUT3
  • Late onset of distant metastases from breast cancer
         ÖZLEM ER1, H ŞENOL COŞKUN1, IŞIN SOYUER2, MUSTAFA ALTINBAŞ1
  • RESULTS OF HIGH DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (APBSCT) IN 45 PATIENTS WITH BREAST CANCER
         AHMET ÖZET1, FİKRET ARPACI1, BEKİR ÖZTÜRK1, CELALETTİN CAMCI2, MÜKERREM SAFALI1, ŞEREF KÖMÜRCÜ1, BÜLENT GÜLEÇ3, İLKER YILMAZ1, HASAN AYTA1, A AYDIN YAVUZ1, YÜCEL PAK1, İDRİS YÜCEL4, ATİLLA YALÇIN2
  • Retrospective evaluation of operated stage I breast cancer patients
         BERNA ÖKSÜZOĞLU, NİLÜFER GÜLER, EŞMEN BALTALI, AZİZ KARAOĞLU, YAVUZ ÖZIŞIK, KADRİ ALTUNDAĞ, GÜLTEN TEKUZMAN
  • Estrogen and Progesterone Receptor Status in Breast Carcinoma: Correlation with Age and Histopathology
         BELKIS ERBAŞ, H. LANGHAMMER, G. SONDERHAUS, R. BUSH
  • CEF Combination as Neoadjuvant Therapy in Stage III Breast Cancer Patients
         EŞMEN BALTALI, SAİME AYŞE KARS, ZAFER ÖNER, YAVUZ ÖZIŞIK, NİLÜFER GÜLER, GÜLTEN TEKUZMAN, DİNÇER FIRAT, İSKENDER SAYEK
  • Acute Lymphoblastic Leukemia in Breast Cancer: A Case Report
         YENER KOÇ, SAİME AYŞE KARS, EMİN KANSU, DİNÇER FIRAT
  • Relations between estrogen receptor status, clinical and histological findings and their prognostic significance in breast carcinoma
         M. TEKİN AKPOLAT, EŞMEN BALTALI , ARZU SUNGUR, İLKSER GULYANAR, ŞEVKET RUACAN, DİNÇER FIRAT, GÜLTEN TEKUZMAN, AYŞE KARS
  • Bilateral breast cancer treatment results and analysis of prognostic factors
         KAYIHAN ENGİN, MUSTAFA ÜNSAL
  • Mucin-like carcinoma-associated antigen and sialic acid in the tissue and blood of patients with primary breast cancer and benign breast disease
         ÇİĞDEM YENİSEY, GÜL GÜNER
  • Phase II study of weekly doses of epirubicin in advanced breast cancer
         DİNÇER FIRAT, EŞMEN BALTALI, FİKRİ İÇLİ, HALUK ONAT, NİL MANDEL, ÖNDER BERK, AHMET OBER, GÜRSEL AKTAN
  • The effect of ondansetron and domperidon as antiemetics in breast cancer patients receiving cyclophosphamide, epirubicin and fluorouracil during three subsequent courses
         PINAR SAİP, HALUK ONAT, SEVİL E. İNANÇ, ERKAN TOPUZ, RİAN DİŞÇİ
  • Weekly doses of epirubicin in locally advanced breast cancer patients as neoadjuvant chemotherapy
         EŞMEN BALTALI, FİKRİ İÇLİ, NİL MOLİNAS MANDEL, HALUK ONAT, GÜRSEL AKTAN, AHMET OBER, NECDET ÜSKENT, MÜNİR KINAY,ÖNDER BERK, DİNÇER FIRAT
  • Phase II study of combination of carboplatin and chronic oral etoposide in pre-treated metastatic breast cancer
         ADNAN EZZAT, SHOUKI BAZARBASHI, AMER RADWI, AHMED EL-WARITH, MADRAS RAJA, MOHAMED RAHAL, JOAN BELENO
  • Multiple primary breast and gynecological cancers
         GALINA CHAKALOVA and ZINAIDA GARANINA
  • Docetaxel (Taxotere) in the salvage treatment of anthracycline resistant metastatic breast cancer
         NİLÜFER GÜLER, EŞMEN BALTALI, KADRİ ALTUNDAĞ, NURULLAH ZENGİN, YAVUZ ÖZIŞIK, GÜLTEN TEKUZMAN, DİNÇER FIRAT
  • Comparison of blue dye and gamma probe guided sentinel lymph node biopsy techniques in breast cancer patients
         ÖMER UĞUR1, M. FANI BOZKURT1, İSKENDER SAYEK2, GÖKHAN GEDİKOĞLU3, ATAÇ BAYKAL2, ERHAN HAMALOĞLU2, İLKER ETİKAN4, ALİ KONAN2, BELKIS ERBAŞ1
  • T3N0M0 Breast cancer patients: A subgroup with favorable prognosis
         MURAT GÜRKAYNAK, FERAH YILDIZ, İ. LALE ATAHAN
  • Reevaluation of baseline staging tests in breast cancer; what should be the standard?
         MUSTAFA SAMUR1, HAKAN ŞAT BOZCUK1, ŞEYDA KARAVELİ2, ELİF PEŞTERELİ2, MUSTAFA ÖZDOĞAN1, MUSTAFA YILDIZ1, MEHMET ARTAÇ1, BURHAN SAVAŞ1
  • The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report
         MUTLU DEMİRAY1, TÜRKKAN EVRENSEL1, ÖZKAN KANAT1, ENDER KURT1, MURAT ARSLAN1, ÖZLEM SARAYDAROLU2, İLKER ERCAN3, GÜZİN GÖNÜLLÜ1, ŞEHSUVAR GÖKGÖZ4, ŞAHSİNE TOLUNAY2, AYŞE GÖZKAMAN1, NALAN AKGÜL1, İSMET TAŞDELEN4, OSMAN MANAVOLU1
  • Treatment approaches for metastatic breast cancer in Turkey
         
  • Adjuvant systemic therapies in women with operable breast cancer: A daily medical practice in a single institution
         BİNNAZ DEMİRKAN1, İLKNUR BİLKAY GÖRKEM2, TÜLAY CANDA3, PINAR BALCI4, ÖMER HARMANCIOĞLU5, SERDAR SAYDAM5, MÜNİR KINAY2, MEHMET ALAKAVUKLAR1
  • Phase II study of gemcitabine plus epirubicin plus paclitaxel in metastatic breast cancer patients
         MUTLU DEMİRAY1, TÜRKKAN EVRENSEL1, MURAT ARSLAN1, ÖZKAN KANAT1, ENDER KURT1, ÖZLEM SARAYDAROĞLU2, İLKER ERCAN3, ŞEHSUVAR GÖKGÖZ4, UĞUR TOPAL5, ŞAHSİNE TOLUNAY2, İSMET TAŞDELEN4, OSMAN MANAVOĞLU1
  • Vinorelbine and cisplatin in metastatic breast cancers
         GÜZİN GÖNÜLLÜ, NEVZAT SELİM, İDRİS YÜCEL
  • Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer
         BİNNAZ DEMİRKAN1, TUĞBA YAVUZŞEN1, MEHMET ALAKAVUKLAR2
  • BRCA1 gene mutation in familial breast cancer
         AMINA EL GEZEERY1, NOHA MAHMOUD1, AMAL MOUSTAFA1, HANAN MAHROUS1, HESHAM MAHMOUD2, NADIA ABD EL-MENAM3
  • Comparison and evaluation of CA 15-3, c-erbB-2, ER and PR tumor markers in pleural fluid cytology from metastatic breast cancer as a diagnostic tool
         SERPİL OĞUZTÜZÜN1, MERAL ATAY2, MURAT KILIÇ1, MÜZEYYEN ÖZHAVZALI3, ZİYA ATAY2
  • Widespread erythematous skin metastasis from breast cancer mimicking generalized drug eruption
         GÜNGÖR UTKAN1, ABDULLAH BÜYÜKÇELİK1, AYLİN HEPER OKÇU3, UFUK AVCI2, BÜLENT YALÇIN1, FİKRİ İÇLİ1
  •  

    Turkish Journal of Cancer web sitesi Novartis Onkoloji'nin karşılıksız eğitim katkılarıyla hazırlanmıştır.
    [ Main Page | Editorial Board | About | Instructions ]
    [ Table of Contents | Archive | Archive Search | Online Submission | E-mail ]